HomeCompareKBBTF vs ORCC

KBBTF vs ORCC: Dividend Comparison 2026

KBBTF yields 208.33% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KBBTF wins by $151.46M in total portfolio value
10 years
KBBTF
KBBTF
● Live price
208.33%
Share price
$0.96
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$151.48M
Annual income
$77,914,744.95
Full KBBTF calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — KBBTF vs ORCC

📍 KBBTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKBBTFORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KBBTF + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KBBTF pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KBBTF
Annual income on $10K today (after 15% tax)
$17,708.33/yr
After 10yr DRIP, annual income (after tax)
$66,227,533.21/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, KBBTF beats the other by $66,227,532.32/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KBBTF + ORCC for your $10,000?

KBBTF: 50%ORCC: 50%
100% ORCC50/50100% KBBTF
Portfolio after 10yr
$75.75M
Annual income
$38,957,372.99/yr
Blended yield
51.43%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

KBBTF
No analyst data
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KBBTF buys
0
ORCC buys
0
No recent congressional trades found for KBBTF or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKBBTFORCC
Forward yield208.33%9.79%
Annual dividend / share$2.00$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$151.48M$21.4K
Annual income after 10y$77,914,744.95$1.04
Total dividends collected$143.08M$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: KBBTF vs ORCC ($10,000, DRIP)

YearKBBTF PortfolioKBBTF Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$31,533$20,833.33$11,190$489.61+$20.3KKBBTF
2$95,137$61,396.68$12,229$256.01+$82.9KKBBTF
3$274,915$173,118.00$13,216$130.74+$261.7KKBBTF
4$761,685$467,526.04$14,207$66.02+$747.5KKBBTF
5$2,025,599$1,210,595.57$15,234$33.17+$2.01MKBBTF
6$5,176,190$3,008,799.54$16,317$16.62+$5.16MKBBTF
7$12,724,177$7,185,654.07$17,468$8.32+$12.71MKBBTF
8$30,123,158$16,508,287.86$18,695$4.16+$30.10MKBBTF
9$68,756,679$36,524,900.02$20,006$2.08+$68.74MKBBTF
10$151,484,391$77,914,744.95$21,407$1.04+$151.46MKBBTF

KBBTF vs ORCC: Complete Analysis 2026

KBBTFStock

Kubota Pharmaceutical Holdings Co., Ltd. develops portfolio of drugs and devices in the ophthalmic field worldwide. Its product pipeline comprises emixustat hydrochloride, which is in Phase III clinical stage used for the treatment of stargardt disease, and Phase II clinical stage used for the treatment of proliferative diabetic retinopathy. The company is also developing remote retinal monitoring device, a home-based and patient self-monitoring optical coherence tomography devices to treat wet age-related macular degeneration and diabetic macular edema, which brings retinal edema and reduction in visual acuity; and wearable device for myopia control. The company was founded in 2002 and is based in Tokyo, Japan.

Full KBBTF Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this KBBTF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KBBTF vs SCHDKBBTF vs JEPIKBBTF vs OKBBTF vs KOKBBTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.